Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study.

Endosc Int Open · 2020 · PMC6976329 · PMID 32010745

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

a decreasing trendP = 0.068so close (0.05 < p ≤ 0.1)

The median AET showed a decreasing trend from 9 % to 0.5 % ( P = 0.068) ( Fig. 4b ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.